NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.41
-0.61 (-3.81%)
Nov 16, 2026, 4:00 PM EST - Market closed

NeoGenomics Revenue

NeoGenomics had revenue of $209.25M in the quarter ending September 30, 2026, with 11.43% growth. This brings the company's total for the last twelve months to $787.75M, up 11.08% year-over-year. In the year 2025, NeoGenomics had annual revenue of $727.33M with 10.11% growth. That makes NeoGenomics the 8,799th largest company in the world by revenue and 1,970th in the United States.

Revenue (ttm)
$787.75M
Revenue Growth
+11.08%
P/S Ratio
2.53
Revenue / Employee
$315,101
Employees
2,500
Market Cap
1.99B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025727.33M66.77M10.11%
Dec 31, 2024660.57M68.92M11.65%
Dec 31, 2023591.64M81.92M16.07%
Dec 31, 2022509.73M25.40M5.24%
Dec 31, 2021484.33M39.88M8.97%
Dec 31, 2020444.45M35.62M8.71%
Dec 31, 2019408.83M132.09M47.73%
Dec 31, 2018276.74M36.49M15.19%
Dec 31, 2017240.25M8.44M3.64%
Dec 31, 2016231.81M132.01M132.27%
Dec 31, 201599.80M12.73M14.62%
Dec 31, 201487.07M20.60M31.00%
Dec 31, 201366.47M6.60M11.02%
Dec 31, 201259.87M16.38M37.68%
Dec 31, 201143.48M9.11M26.51%
Dec 31, 201034.37M4.90M16.63%
Dec 31, 200929.47M9.45M47.23%
Dec 31, 200820.02M8.51M73.97%
Dec 31, 200711.50M5.03M77.65%
Dec 31, 20066.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Sotera Health Company1.23B
OPKO Health654.10M
Veracyte581.78M
CareDx497.40M
GeneDx Holdings460.78M
BillionToOne436.87M
Castle Biosciences377.13M
Adaptive Biotechnologies298.01M
Revenue Rankings